The associations between IL-18 serum levels and the prevalence of metabolic syndrome in polish men over the age of 40 according to other selected inflammatory indices and androgens: Comparison of NCEP with IDF criteria

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 7, 2011, Pages 423-430

  Herman, W A ^a   Lacka K ^b   Kaufman, E ^b   Wojcicka M ^b   Kramer, L ^b   Losy, J ^b,c  

^a HERMED   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

ageing men; androgen deficiency; IL 18; metabolic syndrome

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ANDROGEN; C REACTIVE PROTEIN; INTERLEUKIN 18; PRASTERONE; SULFATE; TESTOSTERONE; TRANSFERRIN;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POLAND; PRIORITY JOURNAL; RURAL AREA; SMOKING;

ADULT; AGE FACTORS; AGED; DEHYDROEPIANDROSTERONE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-18; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLAND; PREVALENCE; TESTOSTERONE;

EID: 79960189974     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1270467     Document Type: Article

References (40)

1. Alberti KG, Eckel RH, Grundy SM et al,. Harmonizing the MS: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association, World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 120 1640-1645
2. Berneis K, Rizzo M, Evans J et al,. Interleukin-18 levels are associated with low-density lipoprotein size. Eur J Clin Invest 2010 40 54-55
3. Blankenberg S, Luc G, Ducimetiere P et al,. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003 108 2453-2459 (Pubitemid 37444405)
4. Bruun JM, Stallknecht B, Helge JW et al,. Interleukin-18 in plasma and adipose tissue: effect of obesity, insulin resistance, and weight loss. Eur J Endocrinol 2007 157 465-471 (Pubitemid 350018450)
5. Brown CD, Higgins M, Donato KA et al,. BMI and prevalence of hypertension and dyslipidemia. Obesity Res 2000 8 605-619
6. Chae C, Lee R, Rifai N et al,. Blood pressure and inflammation in apparently healthy men. Hypertension 2001 38 399-403 (Pubitemid 34225673)
7. Chapman CM, McQuillan BM, Beilby JP et al,. Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population. The Perth Carotid Ultrasound Disease assessment Study (CUDAS). Atherosclerosis 2006 189 414-419 (Pubitemid 44740295)
8. Chen YC, Chang HH, Wen CJ et al,. Elevated serum dehydroepiandrosterone sulphate level correlates with increased risk for metabolic syndrome in the elderly men. Eur J Clin Invest 2010 40 22-225
9. Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory. Semin Nephrol 2007 27 98-114
10. Esposito K, Pontillo A, Ciotola M et al,. Weight loss reduces IL-18 levels in obese women. J Clin Endocrinol Metab 2002 87 3864-3866 (Pubitemid 34879540)
11. Fain JN, Madan AK, Hiler ML et al,. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004 145 2273-2282 (Pubitemid 38535056)
12. Grundy SM, Brewer HB Jr, Cleeman JI et al,. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004 24 13-18
13. Hemingway H, Shipley M, Mullen MJ et al,. Social and physiological influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). Am J Cardiol 2003 92 984-987 (Pubitemid 37214817)
14. Herder C, Baumert J, Kolb H et al,. Circulating levels of interleukin-18 independent of body fat and fat-free mass: results from the MONICA/KORA study. Diabetes Care 2006 29 174-175 (Pubitemid 44033462)
15. Hung J, Knuiman MW, Divitini ML et al,. C-reactive protein and interleukin-18 levels in relation to coronary heart disease: prospective cohort study from Busselton Western Australia. Heart Lung Circ 2008 17 90-95 (Pubitemid 351377554)
16. Hung J, McQuillan BM, Chapman CML et al,. Elevated interleukin-18 levels are associated with metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 2005 25 1268-1273 (Pubitemid 40776620)
17. Janssen I, Katzmarzyk PT, Ross R. BMI, waist circumference, and health risk: evidence in support of current National Institutes of health guidelines. Arch Intern Med 2002 162 2074-2079 (Pubitemid 35168215)
18. Kahn R, Buse J, Ferranini E et al,. The metabolic syndrome; time for a critical appraisal. Joint statement from the American Diabetes Association from the study of Diabetes. Diabetologia 2005 48 1684-1699 (Pubitemid 41317821)
19. Kaptoge S, Di Angelantonio E, Lowe G et al,. Emerging Risk Factor Collaboration C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010 375 132-140
20. Koenig W, Khuseyinova N, Baumert J et al,. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women:results from the MONICA/KORA Augsburg case-cohort study, 19842002. Arterioscler Thromb Vasc Biol 2006 26 275-2751
21. Krogh-Madsen R, Plomgaard P, Moller K et al,. Influence of TNF- and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans. Am J Physiol Endocrinol Metab 2006 291 E 108-E 114
22. Lechleitner M. Obesity and the metabolic syndrome in the elderly a mini review. Gerontology 2008 54 253-259
23. Mamcarz A, Podolec P, Kope G et al,. Polish forum for prevention guidelines on MS. Kardiol Pol 2010 68 121-124
24. Miles EA, Rees D, Banerjee T et al,. Age-related increases in circulatineg inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations. Atherosclerosis 2008 196 298-305
25. Nakamura K, Okamura H, Nagata K et al,. Purification of a factor which provides a costimulatory signal for gamma interferon production. Infect Immun 1993 61 64-70 (Pubitemid 23015400)
26. Nakanishi K, Yoshimoto T, Tsutsui H et al,. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001 19 423-474 (Pubitemid 32368042)
27. Novick D, Kim SH, Fantuzzi G et al,. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999 10 127-136 (Pubitemid 29077390)
28. Olusi SO, Al-Awadhi A, Abraham M. Relations of serum interleukin18 levels to serum lipid and glucose concentrations in an apparently healthy adult population. Horm Res 2003 60 29-33 (Pubitemid 36693883)
29. Phillips AC, Carroll D, Gale CR et al,. Cortisol, DHEAS, their ratio and the metabolic syndrome: evidence from the Vietnam Experience Study. Eur J Endocrinol 2010 162 919-923
30. Ruotsalainen E, Stancakova A, Vauhkonen I et al,. Changes In cytokine levels during acute hyperinsulinemia in offspring of type 2 diabetic subjects. Atherosclerosis 2010 210 536-541
31. Skurk T, Kolb H, Muller-Scholze S et al,. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol 2005 152 863-868 (Pubitemid 40903576)
32. Steinberg D. Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nat Med 2002 8 1211-1217 (Pubitemid 35373551)
33. Stenholm S, Koster A, Alley DE et al,. Adipocytokines and the metabolic syndrome among older persons with and without obesity the InCHIANTI Study. Clin Endocrinol (Oxf) 2009 73 55-65
34. Sugama S, Conti B. Interleukin-18 and stress. Brain Res Rev 2008 58 85-95
35. Tannenbaumm C, Barrett-Connor E, Laughlin GA et al,. A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the Rancho Bernardo Study. Eur J Endocrinol 2004 151 717-725 (Pubitemid 40090011)
36. The IDF consensus worldwide definition of the metabolic syndrome. Berlin 14th April 2005 info@idf.org www.idf.org
37. Thorand B, Kolb H, Baumert J et al,. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 19842002. Diabetes 2005 54 2932-2938 (Pubitemid 41401089)
38. Troseid M, Seljeflot I, Hjerkinn EM et al,. Interleukin-18 is a strong predictor of cardiovascular events in elderly men with metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes Care 2009 32 486-492
39. Welsh P, Woodward M, Rumley A et al,. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol 2008 141 852-861 (Pubitemid 351724867)
40. Zirlik A, Abdullah SM, Gerdes N et al,. Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis. Results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol 2007 27 2043-2049 (Pubitemid 47312316)